comparemela.com

Latest Breaking News On - Coagulant therapeutics corporation - Page 1 : comparemela.com

Coagulant Therapeutics Announces Publication in Blood Advances Describing Novel Nanobody Library to Activated Protein C (APC) and Initial Leads for Treatment of Trauma and Hemophilia

/PRNewswire/ Coagulant Therapeutics Corporation, a privately held company focused on the design, development and commercialization of therapeutics targeted.

United statesLaurent mosnierEliza schleifsteinTerry hermistonScripps research instituteSite targeting nanobody libraryJournal of the american society hematologyAntibody programProfessor in department of molecular medicinePrnewswire coagulant therapeutics corporationAntibody libraryCoagulant therapeutics corporationManuscript characterizes novelTherapeutics corporationActivated proteinc activitiesNon active site targeting nanobody

Coagulant Therapeutics Presents Data on an Exosite-Specific Nanobody Library to Activated Protein C (APC) at the 2022 American Society of Hematology (ASH) Annual Meeting

/PRNewswire/ Coagulant Therapeutics Corporation, a privately held company focused on the design, development and commercialization of therapeutics targeted.

United statesNew orleansDerek simEliza schleifsteinTerry hermistonNanobody libraryAmerican society of hematology annual meetingCoagulant therapeutics corporationAntibody programPrnewswire coagulant therapeutics corporationTherapeutics corporationActivated proteinc activitiesExosite specific nanobodyAmerican societyHematology annual meetingChief scientific officer

Coagulant Therapeutics Presents Data on an Exosite-Specific Nanobody Library to Activated Protein C (APC) at the 2022 American Society of Hematology (ASH) Annual Meeting

/PRNewswire/ Coagulant Therapeutics Corporation, a privately held company focused on the design, development and commercialization of therapeutics targeted.

United statesNew orleansDerek simEliza schleifsteinTerry hermistonNanobody libraryAmerican society of hematology annual meetingCoagulant therapeutics corporationAntibody programPrnewswire coagulant therapeutics corporationTherapeutics corporationActivated proteinc activitiesExosite specific nanobodyAmerican societyHematology annual meetingChief scientific officer

Coagulant Therapeutics Announces Upcoming Oral and Poster Presentations at the 2022 American Society of Hematology (ASH) Annual Meeting

/PRNewswire/ Coagulant Therapeutics Corporation, a privately held company focused on the design, development and commercialization of therapeutics targeted.

United statesNew orleansDerek simEliza schleifsteinAmerican society of hematologyNanobody libraryCoagulant therapeutics corporationAntibody programAmerican societyAnnual meetingSelective modulationActivated proteinc activitiesExosite specific nanobodyRapid clearing factorProvides pro hemostatic activityReduce blood loss

Coagulant Therapeutics Presents Data for Severe Postpartum Hemorrhage Clinical Candidate, CT-001, at International Society for Thrombosis and Haemostasis Congress

/PRNewswire/ Coagulant Therapeutics Corporation, a privately held company focused on the research, development and commercialization of therapeutics.

United statesCity ofUnited kingdomDerek simEliza schleifsteinTerry hermistonInternational society on thrombosisDrug administrationCoagulant therapeutics corporationInternational societyChief scientific officerCoagulant therapeuticsVice presidentHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveries

vimarsana © 2020. All Rights Reserved.